Abstract

AVALOS GARCIA, Roxana et al. New challenges in the treatment of the infection for helicobacter pylori. Rev.Med.Electrón. [online]. 2019, vol.41, n.4, pp.979-992.  Epub Aug 30, 2019. ISSN 1684-1824.

The infection for helicobacter pylori affects approximately to the world population's 50%, it is causing of chronic gastritis, peptic ulcer, gastric cancer and linfoma associated to the mucous one. From their discovery, the eradication has been one of the most important challenges in Gastroenterología. In many countries the prevalencia of primary resistance is ignored from the microorganism to the different antibiotics that empirically they are used, and for not carrying out routine tests that verify its eradication in the daily practice, the effectiveness of the prescribed outlines it is ignored. The progressive increment of the resistance to the claritromicina and metronidazol, together to an absence of alternative antibioticotherapy, challenges the capacity to eliminate from an effective way to this bacteria. The bismuth subcitrato has resurged and its addition in the therapy has allowed to increase the cure rates above 90%. At the moment it is invoked that to improve the effectiveness in the treatment, that is should combine a potent suppression of the gastric acid in combined quadruple treatments with a duration of 14 days, for most of the cases. The adherence to the treatment is crucial to obtain therapeutic good results.

Keywords : Helicobacter pylori; chronic gastritis; gastric cancer; primary resistance; quadruple treatments.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )